Imunon
IMNN
17 hedge funds and large institutions have $1.09M invested in Imunon in 2017 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 6 increasing their positions, 1 reducing their positions, and 6 closing their positions.
500% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 1
0% less ownership
Funds ownership: 0.01% → 0% (-0%)
26% less funds holding
Funds holding: 23 → 17 (-6)
28% less capital invested
Capital invested by funds: $1.51M → $1.09M (-$420K)
50% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$326K |
| 2 |
Renaissance Technologies
New York
|
+$217K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$79.1K |
| 4 |
Jane Street
New York
|
+$44.7K |
| 5 |
PAM
Panagora Asset Management
Boston,
Massachusetts
|
+$16.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
-$416K |
| 2 |
AFM
Anson Funds Management
Dallas,
Texas
|
-$200K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$38.7K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$28.4K |
| 5 |
Citadel Advisors
Miami,
Florida
|
-$21.5K |
IMNN Hedge Fund Activity: Q1 2017 in Review
17 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q1 2017, worth a combined $1.09M — down 28% from $1.51M a quarter earlier.
Sellers outnumbered buyers: 6 funds closed out of IMNN and 3 opened new positions — a net loss of 3 holders — while 1 trimmed existing stakes and 6 added.
The largest buyer was BlackRock, adding an estimated $326K. The largest seller was Sabby Management, exiting entirely with an estimated $416K sold.
- 17 institutional investors held Imunon (IMNN) as of Q1 2017, down from 23 in Q4 2016.
- Funds reported $1.09M of Imunon stock for Q1 2017, down 28% quarter-over-quarter.
- 3 funds opened new Imunon positions in Q1 2017 and 6 closed out, a net change of -3 holders.
- The largest Imunon buyer in Q1 2017 was BlackRock, an estimated $326K added.
- The largest Imunon seller in Q1 2017 was Sabby Management, an estimated $416K sold.
Based on aggregated 13F filings for Q1 2017.